Practical considerations for clinicians for transitioning patients on maintenance therapy with olaparib capsules to the tablet formulation of olaparib

Friedlander, M; Shannon, C; Goh, J; Scott, C; Mileshkin, L

Friedlander, M (reprint author), Prince Wales Hosp, Dept Med Oncol, Barker St, Randwick, NSW 2031, Australia.

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018; 14 (6): 459

Abstract

Purpose Olaparib was originally formulated as 50 mg capsules with a recommended dose of 400 mg twice daily which requires patients to take 16 capsules......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索